For: | Munoz-Garrido P, Fernandez-Barrena MG, Hijona E, Carracedo M, Marín JJG, Bujanda L, Banales JM. MicroRNAs in biliary diseases. World J Gastroenterol 2012; 18(43): 6189-6196 [PMID: 23180938 DOI: 10.3748/wjg.v18.i43.6189] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i43/6189.htm |
Number | Citing Articles |
1 |
Zhenhua Luo, Anil G. Jegga, Jorge A. Bezerra. Gene‐disease associations identify a connectome with shared molecular pathways in human cholangiopathies. Hepatology 2018; 67(2): 676 doi: 10.1002/hep.29504
|
2 |
Torsten Voigtländer, Shashi K. Gupta, Sabrina Thum, Jasmin Fendrich, Michael P. Manns, Tim O. Lankisch, Thomas Thum, Wing-Kin Syn. MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma. PLOS ONE 2015; 10(10): e0139305 doi: 10.1371/journal.pone.0139305
|
3 |
Jose J.G. Marin, Luis Bujanda, Jesus M. Banales. MicroRNAs and cholestatic liver diseases. Current Opinion in Gastroenterology 2014; 30(3): 303 doi: 10.1097/MOG.0000000000000051
|
4 |
K-Y Lin, H Ye, B-W Han, W-T Wang, P-P Wei, B He, X-J Li, Y-Q Chen. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma. Oncogene 2016; 35(26): 3376 doi: 10.1038/onc.2015.396
|
5 |
Aitor Esparza-Baquer, Ibone Labiano, Luis Bujanda, María J. Perugorria, Jesús M. Banales. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools. Clinics and Research in Hepatology and Gastroenterology 2016; 40(1): 15 doi: 10.1016/j.clinre.2015.10.001
|
6 |
Keisaku Sato, Shannon Glaser, Heather Francis, Gianfranco Alpini. Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00048
|
7 |
Steven P. O’Hara, Sergio A. Gradilone, Tetyana V. Masyuk, James H. Tabibian, Nicholas F. LaRusso. MicroRNAs in Cholangiopathies. Current Pathobiology Reports 2014; 2(3): 133 doi: 10.1007/s40139-014-0048-9
|
8 |
P. Olaizola, P.Y. Lee-Law, A. Arbelaiz, A. Lapitz, M.J. Perugorria, L. Bujanda, J.M. Banales. MicroRNAs and extracellular vesicles in cholangiopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1293 doi: 10.1016/j.bbadis.2017.06.026
|
9 |
Irene K. Yan, Valentin X. Berdah, Tushar Patel. Extracellular RNA. Methods in Molecular Biology 2018; 1740: 59 doi: 10.1007/978-1-4939-7652-2_6
|
10 |
Thijs R. M. Barten, Lucas H. P. Bernts, Joost P. H. Drenth, Tom J. G. Gevers. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease. Expert Opinion on Therapeutic Targets 2020; 24(6): 589 doi: 10.1080/14728222.2020.1751818
|
11 |
Yemiao Chen, Catherine M. Verfaillie. MicroRNAs: the fine modulators of liver development and function. Liver International 2014; 34(7): 976 doi: 10.1111/liv.12496
|
12 |
M. Cahová, H. Daňková, M. Heczková, M. Brátová, N. Ďásková, H. Baštová, J. Gojda, P. Wohl. MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients. Physiological Research 2019; : 681 doi: 10.33549/physiolres.934103
|
13 |
Anne-Margarethe Enge, Heike Sprenger, Albert Braeuning, Stefanie Hessel-Pras. Identification of microRNAs Implicated in Modulating Senecionine-Induced Liver Toxicity in HepaRG Cells. Foods 2022; 11(4): 532 doi: 10.3390/foods11040532
|
14 |
Youwen Tan, Tengli Pan, Yun Ye, Guohong Ge, Li Chen, Danfeng Wen, Shengqiang Zou, Aftab A. Ansari. Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis. PLoS ONE 2014; 9(10): e111424 doi: 10.1371/journal.pone.0111424
|
15 |
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?. Journal of Clinical Medicine 2015; 4(12): 2028 doi: 10.3390/jcm4121958
|
16 |
Douglas V.N.P. Oliveira, Shanshan Zhang, Xin Chen, Diego F. Calvisi, Jesper B. Andersen. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets. Expert Review of Gastroenterology & Hepatology 2017; 11(4): 349 doi: 10.1080/17474124.2017.1292127
|
17 |
Maria Pisarello, Lorena Loarca, Tommy Ivanics, Leslie Morton, Nicholas LaRusso. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment. Journal of Clinical Medicine 2015; 4(9): 1688 doi: 10.3390/jcm4091688
|
18 |
Céline Demarez, Catherine Hubert, Christine Sempoux, Frédéric P. Lemaigre, Heather Francis. Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma. PLOS ONE 2016; 11(6): e0157140 doi: 10.1371/journal.pone.0157140
|
19 |
A.E. Abaturov, V.L. Babуch. The role of miRNAs in the development of cholangiopathies. Part 1. CHILD`S HEALTH 2023; 18(4): 323 doi: 10.22141/2224-0551.18.4.2023.1606
|
20 |
Zheng Fang, Lei Lu, Zhiqiang Tian, Kunlun Luo. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma. Medical Oncology 2014; 31(5) doi: 10.1007/s12032-014-0940-5
|
21 |
Ning Wang, Shihai Xia, Kai Chen, Xiaohui Xiang, Aijun Zhu. Genetic alteration regulated by microRNAs in biliary tract cancers. Critical Reviews in Oncology/Hematology 2015; 96(2): 262 doi: 10.1016/j.critrevonc.2015.05.015
|
22 |
Pablo Letelier, Ismael Riquelme, Alfonso Hernández, Neftalí Guzmán, Jorge Farías, Juan Roa. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. International Journal of Molecular Sciences 2016; 17(5): 791 doi: 10.3390/ijms17050791
|
23 |
Fang Bao, Jiayue Liu, Haiyang Chen, Lu Miao, Zhaochao Xu, Guixin Zhang. Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study. Cancers 2022; 14(16): 3921 doi: 10.3390/cancers14163921
|